IPO

Bill Ackman takes to X Spaces to answer for his new funds' rocky debut. What's the strategy behind the dual IPO and can he calm investor nerves?

Collective Acquisition Corp. II, led by finance vets and military leaders, closes a $220M IPO to hunt for deals in defense tech, AI, and strategic resources.

Scentre Group's tender offer for its 2080 notes expires today, leveraging a key clause to push for a full repurchase and reshape its financial future.

Activist investor Trian Fund Management launches a public campaign against Solventum, alleging massive value destruction and excessive executive compensation.

Despite a 19% revenue jump amidst Greece's record tourism year, hotel group The Azur Selection posts a €5.7M loss, triggering a 'going concern' warning.

The creator commerce agency is redefining partnerships by offering influencers an ownership stake in its final private funding round before a public offering.

An energy tech firm closes a landmark $25M offering and seeks more to fund its $850M zero-waste facility, betting on a clean future for coal.

A new platform aims to replace AI's legal battles over content with a marketplace for consent, control, and compensation for creators and individuals.

As prediction markets boom, Shift Markets launches a white label solution enabling trading platforms to easily enter the fast-growing event-trading sector.

HERNEST's new FSC-certified teak collection meets soaring consumer demand for sustainability with furniture designed for real life and a greener planet.

Celebrating a 25-year milestone, the leader in Catholic-value investing launches its Undiscovered Fund, blending strict moral screens with a new growth strategy.

Singapore's TechCreate reports 54% revenue growth and a quantum tech leap, but a regulatory trading halt has left investors and the market in the dark.

Fintech firm Wahed launches a first-of-its-kind, zero-debt real estate fund for all US investors, opening the single-family rental market for just $100.

Former HHS Secretary Tommy Thompson joins Vector Science & Therapeutics, leveraging his political clout to advance a novel transdermal drug delivery platform.

Arkay Beverages plans a global network of zero-proof bars, banking on a unique molecule and a $1.5B NASDAQ goal. But can it deliver a true alternative?

The Canadian miner's new OTCQB listing aims to attract American capital, fueling exploration of its promising gold and copper assets in British Columbia.

South Korea approves its first homegrown CAR-T therapy, a landmark achievement offering new hope for lymphoma patients with impressive response rates.

With a 104B-parameter AI and soaring revenue, Diagens is industrializing diagnostics. Can its ambitious 'Model-as-a-Service' clear global regulatory barriers?

Regency Centers posts strong Q1 results, beating estimates and raising guidance, proving the resilience of grocery-anchored suburban shopping centers.

Webster Financial affirms shareholder returns with a new dividend, backed by strong Q1 earnings, as a major acquisition by Banco Santander looms.